Effects of tirofiban on large vessel occlusion stroke are modified by etiology and renal function
Abstract Objective Renal function can modify the outcomes of large vessel occlusion (LVO) stroke across stroke etiologies in disparate degrees. The presence of renal function deficit can also impair the pharmacokinetics of tirofiban. Hence, this study aimed to investigate the roles of renal function...
Main Authors: | Chang Liu, Fengli Li, Liyuan Chen, Jiacheng Huang, Hongfei Sang, Thanh N. Nguyen, Jeffrey L. Saver, Mohamad Abdalkader, Weiling Kong, Jie Yang, Changwei Guo, Chen Gong, Liping Huang, Yanzhu Pan, Xinxin Wang, Yangmei Chen, Zhongming Qiu, Wenjie Zi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-03-01
|
Series: | Annals of Clinical and Translational Neurology |
Online Access: | https://doi.org/10.1002/acn3.51982 |
Similar Items
-
Local tirofiban infusion for remnant stenosis in large vessel occlusion: tirofiban ASSIST study
by: Yong-Won Kim, et al.
Published: (2020-07-01) -
Adjunct Intraarterial or Intravenous Tirofiban Versus No Tirofiban After Successful Recanalization of Basilar Artery Occlusion Stroke: The BASILAR Registry
by: Huagang Li, et al.
Published: (2024-03-01) -
Intravenous tirofiban following successful reperfusion in intracranial large artery atherosclerotic stroke: A secondary analysis of a randomized clinical trial
by: Jiacheng Huang, et al.
Published: (2023-11-01) -
There is no difference in safety and efficacy with Tirofiban or Eptifibatide for patients undergoing treatment of large vessel occlusion and underlying intracranial atherosclerosis
by: Hari Movva, et al.
Published: (2021-03-01) -
Safety and Efficacy of Tirofiban Combined With Mechanical Thrombectomy Depend on Ischemic Stroke Etiology
by: Chao Sun, et al.
Published: (2019-10-01)